top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration
The prevalence of 3,4-methylenedioxymethamphetamine (MDMA) consumption is relatively high in Aotearoa New Zealand, but MDMA use has not been
Jai Whelan, Geoff Noller, and Ryan D Ward
Aug 18, 20242 min read
Allaying the fears: MDMA with therapy is a medicine
MDMA has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies as a novel treatment for PTSD.
Prof David Nutt, Tadeusz Hawrot, Peter Hunt, and Dr Anne Katrin Schlag
Aug 6, 202425 min read
In defence of the decriminalisation of drug possession in the UK
Authors Alex Stevens, Niamh Eastwood and Kirstie Douse Published March 24, 2024 Abstract In this review article, we develop the case for...
Alex Stevens, Niamh Eastwood and more
Mar 24, 20241 min read
Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
Authors Ksenia Cassidy, CJ Healy, Eva Henje and Wendy D’Andrea Published March 20, 2024 Abstract Challenging experiences in ayahuasca...
Ksenia Cassidy, Eva Henje and more
Mar 20, 20241 min read
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study
Authors Simon GD Ruffell, Sam Gandy, WaiFung Tsang, Rono Lopez, Nathan O’Rourke, Arsalan Akhtar, Nige Netzband, Jack Hollingdale, Daniel...
Simon Ruffell, Sam Gandy, and more
Feb 28, 20242 min read
A history of the European Medical Society for Psycholytic Therapy (EPT) 1964–1974
Authors Torsten Passie Published February 22, 2024 Abstract The emergence of a so-called psychedelic renaissance has been proposed to...
Torsten Passie
Feb 22, 20241 min read
Investigation of the household storage of medicines and disposal practices in Parklands sub-county in Nairobi, Kenya
Over time there has been an increase in access to medicine, leading to the bulk of drugs becoming unused and being kept at home.
Shreya Malde and Naumih Noah
Jan 31, 20242 min read
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Minorities’ diminished psychedelic returns: Cardio-metabolic health. Race differences remain a critically understudied gap in psychedelic li
Sean Matthew Viña
Jan 9, 20241 min read
Counting and accounting for drug-related deaths at UK music festivals 2017–2023: A commentary
The exact number of drug-related deaths at UK music festivals in recent years is unknown, and there are no standard processes for reporting
Tom Cooney and Fiona Measham
Nov 21, 20231 min read
Decrypting the cryptomarkets: Trends over a decade of the Dark Web drug trade
The Dark Web is a subsection of the Internet only accessible through specific search engines, making it impossible to trace users.
Harjeev Kour Sudan, Jane Kim and more
Nov 19, 20232 min read
The impact of over the counter and prescription medication misuse on friends and family
Over the counter and prescription-only medication misuse is of concern. Little is known about the impact on friends/family who provide indiv
Rosalind Gittins, Roya Vaziri, and more
Nov 16, 20232 min read
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
On February 3, 2023, the Therapeutic Goods Administration (TGA), Australian Government Department of Health and Aged Care, announced that on
Octavian Dixon Ritchie, Cameron Donley and more
Sep 7, 20231 min read
Racial and religious motives for drug criminalization
The world has a long-standing system of drug control intended to suppress the use of a range of psychoactive drugs on the basis that such us
Petter Grahl Johnstad
Sep 6, 20231 min read
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
PTSD in adolescence causes much suffering and has substantial health-care costs. The purpose of this study is to investigate the perspective
Anoek Van Vugt, Josjan Zijlmans and more
Sep 2, 20231 min read
Perceived barriers to access to hepatitis C for people who inject drugs in Morocco: A qualitative explorative study
Worldwide, approximately there are 15.6 million people who inject drugs. Recently, a rising prevalence of hepatitis C virus among the people
Zakaria Belrhiti and Fatima Zohra Serghini
Sep 1, 20232 min read
Could classic psychedelics influence immigrants’ acculturation process? A narrative review contemplating how
Rising international migration, paired with increasing public support for far-right political parties, poses a growing challenge to the coun
Benjamin Korman
Jul 31, 20231 min read
A phenomenological analysis of Fellini's films to understand the effect of LSD therapy on his creativity
Since its discovery in 1943, LSD has been used by artists, scientists, and intellectuals, amongst others, to stimulate their creative insigh
Antonio Metastasio, Silvio Mignogna, and more
Jul 31, 20231 min read
Impact of the introduction of medical cannabis in the UK on risk perception and recreational use of cannabis: A longitudinal and cross-sectional analysis
Cannabis was rescheduled in the UK in November 2018 so that it can now be prescribed as a treatment for certain medical conditions.
Jon Waldron, Meryem Grabski, and more
Jul 10, 20232 min read
Minorities’ diminished psychedelic returns
Although there is a growing support for the use of psychedelics to improve the health of marginalized groups, there are some critical gaps.
Sean Viña and Amanda Stephens
Jun 23, 20231 min read
Italian psychedelic therapies of the past century: An historical overview
In recent years, the historical record of psychedelic therapy in Europe and the Americas has undergone considerable revision.
Adriana D’Arienzo and Giorgio Samorini
Jun 6, 20231 min read
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model
There is growing evidence to support the use of the psychedelic drug psilocybin for difficult-to-treat depression. This paper compares the c
Paul McCrone, Henry Fisher and more
Jun 2, 20232 min read
bottom of page